Inflammation markers predicting frailty and mortality in the elderly.
Greater numbers of individuals are living to older ages. A major concern at both individual and population levels is how to live these years at a high functional level. If we had physiological markers to identify those at risk for progressive functional decline and impeding death, therapies could be targeted towards these individuals to prevent adverse outcomes. Senescence is presently considered as the consequence of lifelong antigenic stress impinging upon the individual genetic background. We might consider inflammation markers as synthetic measures of lifelong attrition combined with genetic tendency to develop an inflammatory phenotype. Such biomarkers are the most powerful predictors of frailty and mortality in the elderly available today. The aim of this review is to translate results from the research on ageing into a practical view, suggesting new tools for the clinical approach to older people.
De Martinis
Massimo
M
Department of Internal Medicine, University of L'Aquila, Via S.Sisto, 22/E, 67100 L'Aquila, Italy.
Franceschi
Claudio
C
Monti
Daniela
D
Ginaldi
Lia
L
D000368:Aged / Q000502:physiology*; D000369:Aged, 80 and over / Q000502:physiology*; D000375:Aging / Q000276:immunology*; D015415:Biomarkers; D016330:Frail Elderly; D006801:Humans; D007249:Inflammation / Q000503:physiopathology*
D015415:Biomarkers